Metraipolis › archive › dc_538ea86c9ff3

YPEL1 Inhibits Development of Gemcitabine Resistance in NK / T Cell Lymphomas — Europe PMC PMID:40103457

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40103457
DOI
10.2174/0115680096328745250122231110
License (as archived)
solo-consultazione
Archived
2026-11-07T03:57:43.565Z
SHA-256 of the archived text
8850620feaabe29377f8352c8c80798e1876a40c0098aba0b484bd97e9c336e8
Stable URL of this page
https://metraipolis.com/documento/dc_538ea86c9ff3

How to cite

YPEL1 Inhibits Development of Gemcitabine Resistance in NK / T Cell Lymphomas — Europe PMC PMID:40103457 — Europe PMC (en), https://europepmc.org/article/MED/40103457 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_538ea86c9ff3 (Metraipolis archive dc_538ea86c9ff3, sha256 8850620feaabe29377f8352c8c80798e1876a40c0098aba0b484bd97e9c336e8)
BibTeX
@misc{dc538ea86c9ff3,
  title = {YPEL1 Inhibits Development of Gemcitabine Resistance in NK / T Cell Lymphomas — Europe PMC PMID:40103457},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40103457},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_538ea86c9ff3; sha256 8850620feaabe29377f8352c8c80798e1876a40c0098aba0b484bd97e9c336e8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40103457. Agents can read the archived copy with the MCP tool read_document.